• 
  Shimrat Mamrut, Nili Avidan, Frédérique Truffault, Elsebeth Staun-Ram, Tarek Sharshar, et al.. Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins. Journal of Autoimmunity, 2017, 82, pp.62-73. ⟨10.1016/j.jaut.2017.05.005⟩. ⟨hal-03824048⟩
• 
  Maartje Huijbers, Alexander Marx, Jaap Plomp, Rozen Le Panse, William Phillips. Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders. The Lancet Neurology, 2022, 21 (2), pp.163-175. ⟨10.1016/S1474-4422(21)00357-4⟩. ⟨hal-03563023⟩
• 
  Déborah Cardoso. Rôle de la PARylation sur l’apparition des troubles cardiovasculaires dans la progéria de Hutchinson-Gilford. Médecine humaine et pathologie. Sorbonne Université, 2022. Français. ⟨NNT : 2022SORUS020⟩. ⟨tel-03973171⟩
• 
  José A Villegas, Jérôme van Wassenhove, Judith Merrheim, Karen Matta, Samy Hamadache, et al.. Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis. Journal of Neuroinflammation, 2023, 20 (1), pp.9. ⟨10.1186/s12974-023-02691-3⟩. ⟨hal-03972909⟩
• 
  Julien Verdier, Odessa-Maud Fayet, Edouard Hemery, Frédérique Truffault, Natalia Pinzón, et al.. Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells. Frontiers in Immunology, 2023, 14, ⟨10.3389/fimmu.2023.1083218⟩. ⟨hal-03972888⟩
• 
  Marion Brisset, Rabah Ben Yaou, Robert-Yves Carlier, Anaїs Chanut, Guillaume Nicolas, et al.. X-linked Emery–Dreifuss muscular dystrophy manifesting with adult onset axial weakness, camptocormia, and minimal joint contractures. Neuromuscular Disorders, 2019, 29 (9), pp.678-683. ⟨10.1016/j.nmd.2019.06.009⟩. ⟨hal-03864398⟩
• 
  Céline Tard, Vincent Tiffreau, Emmanuelle Jaillette, Fabienne Jouen, Isabelle Nelson, et al.. Anti-HMGCR antibody–related necrotizing zutoimmune myopathy mimicking muscular dystrophy. Neuropediatrics, 2017, 48 (06), pp.473-476. ⟨10.1055/s-0037-1604402⟩. ⟨hal-03855669⟩
• 
  Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-03832478⟩
• 
  Guillaume Breton, Gabrièle Laborde-Balen, Foromo Guilavogui, Saidi Karemangino, Daniel K Zana, et al.. HIV viral load algorithm. AIDS, 2020, 34 (1), pp.159 - 160. ⟨10.1097/qad.0000000000002382⟩. ⟨hal-03948649⟩
• 
  Valerie Matagne, Yann Ehinger, Lydia Saidi, Ana Borges-Correia, Martine Barkats, et al.. A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome. Neurobiology of Disease, 2017, 99, ⟨10.1016/j.nbd.2016.12.009⟩. ⟨hal-01426386⟩
• 
  Giorgia Querin, Timothée Timothée Lenglet, Rabab Debs, Tanya Stojkovic, Anthony Behin, et al.. Development of new outcome measures for adult SMA type III and IV: a multimodal longitudinal study. Journal of Neurology, 2021, 268 (5), pp.1792-1802. ⟨10.1007/s00415-020-10332-5⟩. ⟨hal-03230903⟩
• 
  Caroline Le Dour, Maria Chatzifrangkeskou, Coline Macquart, Maria M Magiera, Cécile Peccate, et al.. Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations. Nature Communications, 2022, 13 (1), pp.7886. ⟨10.1038/s41467-022-35639-x⟩. ⟨hal-03921784⟩
• 
  Deborah Cardoso. Rôle de la PARylation sur l’apparition des troubles cardiovasculaires dans la progéria de Hutchinson-Gilford. Cardiologie et système cardiovasculaire. Sorbonne Universites, UPMC University of Paris 6, 2022. Français. ⟨NNT : ⟩. ⟨tel-03886230⟩
• 
  Antoine de Zélicourt, Abdallah Fayssoil, Mbarka Dakouane‐giudicelli, Isley de Jesus, Ahmed Karoui, et al.. CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype. EMBO Molecular Medicine, 2022, 14, ⟨10.15252/emmm.202012860⟩. ⟨hal-03875071⟩
• 
  Leandro Ladislau, Débora M Portilho, Tristan Courau, Alhondra Solares-Pérez, Elisa Negroni, et al.. Activated dendritic cells modulate proliferation and differentiation of human myoblasts. Cell Death and Disease, 2018, 9 (5), pp.551. ⟨10.1038/s41419-018-0426-z⟩. ⟨hal-03868139⟩
• 
  Jean-Thomas Vilquin. Approches de thérapies cellulaires et géniques dans le contexte des maladies musculaires squelettiques et cardiaques. Biologie cellulaire. Université Pierre et Marie Curie (Paris 6), Sorbonne Universités, 2013. ⟨tel-03824567⟩
• 
  Antoine Mérien, Julie Tahraoui-Bories, Michel Cailleret, Jean-Baptiste Dupont, Céline Leteur, et al.. CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis. Human Molecular Genetics, 2022, 31 (1), pp.41-56. ⟨10.1093/hmg/ddab218⟩. ⟨hal-03830948⟩
• 
  Alexandra Monceau, Clément Delacroix, Mégane Lemaitre, Gaelle Revet, Denis Furling, et al.. The beneficial effect of chronic muscular exercise on muscle fragility is increased by Prox1 gene transfer in dystrophic mdx muscle. PLoS ONE, 2022, 17 (4), pp.e0254274. ⟨10.1371/journal.pone.0254274⟩. ⟨hal-03830867⟩
• 
  Ludovic Arandel, Magdalena Matloka, Arnaud F Klein, Frédérique Rau, Alain Sureau, et al.. Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats. Nature Biomedical Engineering, 2022, 6 (2), pp.207-220. ⟨10.1038/s41551-021-00838-2⟩. ⟨hal-03830811⟩
• 
  Laure de Pontual, Geneviève Gourdon, Stéphanie Tomé. Identification of new factors inducing CTG.CAG repeat contractions in Myotonic Dystrophy type 1. médecine/sciences, 2021, 37, pp.6 - 10. ⟨10.1051/medsci/2021182⟩. ⟨hal-03753522⟩

686

904